24. Shewry PR, Tatham AS, Kasarda DD (1992) Cereal proteins and coeliac disease. In: Marsch M, ed. Coeliac disease. Oxford: Blackwell Scientific Publications. pp 305–348. 25. Ellis HJ, Freedman AR, Ciclitira PJ (1990) Detection and estimation of the barley prolamin content of beer and malt to assess their suitability for patients with coeliac disease. Clin Chim Acta 189: 123–130. 26. Ellis HJ, Doyle AP, Day P, Wieser H, Ciclitira PJ (1994) Demostration of the presence of coeliac-activating gliadin-like epitopes in malted barley. Int Arch Allergy Inmunol 104: 308–310. 27. Stepniak D, Koning F (2006) Celiac disease-sandwiched between innate and adaptive immunity. Human Immunol 67: 460–468. 28. Cerf-Bensussan N, Matysiak-Budnik T, Cellier C, Heyman M (2007) Oral proteases: a new approach to managing coeliac disease. Gut 56: 157–160. 29. Skovbjerg H, Koch C, Anthonsen D, Sjo¨stro¨m H (2004) Deamidation and cross- linking of gliadin peptides by transglutaminases and the relation to celiac disease. Biochim Biophys Acta 1690: 220–230. 30. Fehniger TA, Caligiuri MA (2001) Interleukin 15: biology and relevance to human disease. Blood 97: 14–32. 31. Bernardo D, Garrote JA, Ferna´ndez-Salazar L, Riestra S, Arranz E (2007) Is gliadin really safe for non-celiac individuals? Production of interleukin 15 in biopsy culture from non-celiac individuals challenged with gliadin peptides. Gut 56: 889–890. 32. Valde´s I, Garc´ıa E, Llorente M, Me´ndez E (2003) Innovative approach to low- level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol. Eur J Gastroenterol Hepatol 15: 465–474. MoAbs to Toxic Gluten Peptides 33. Spaenij-Dekking EHA, Kooy-Winkelaar EMC, Nieuwenhuizen WF, Drijfhout JW, Koning F (2004) A novel and sensitive method for the delection of T cell stimulatory epitopes of a/b- and c-gliadin. Gut 53: 1267–1273. 34. Gianfrani C, Siciliano RA, Facchiano AM, Camarca A, Mazzeo MF, et al. (2007) Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 133: 780–789. 35. Tepnel Biosystems. Gluten assay kit, for the quantitative determination of gluten in food products by enzyme immunoassay. Tepnel Biosystems, UK. 36. Hill ID, Dirks MH, Liptak GS, Colleti RB, Fasano A, et al. (2005) Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Ped Gastroenterol Nutr 40: 1–19. 37. Catassi C, Fabiani E, Iacono G, D’Agate C, Francavilla R, et al. (2007) A prospective, double-bind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 85: 160–166. 38. Xia J, Sollid LM, Khosla C (2005) Equilibrium and kinetic analysis of the unusual binding behavior of a highly immunogenic gluten peptide to HLA- DQ2. Biochem 44: 4442–4449. 39. Vora H, McIntire J, Kumar P, Deshpande M, Khosla C (2007) A scaleable manufacturing process for pro-EP-B2, a cysteine protease from barley indicated for celiac sprue. Biotechnol Bioeng 98: 177–185. 40. Cebolla A, Sousa C, de Lorenzo V (2001) Rational design of a bacterial transcriptional cascade for amplifying gene expression capacity. Nucl Acids Res 29: 759–766. 41. Cebolla A, Royo JL, de Lorenzo V, Santero E (2002) Improvement of recombinant protein yield by a combination of transcriptional amplification and stabilization of gene expression. App Environ Microbiol 68: 5034–5041. PLoS ONE | www.plosone.org 13 May 2008 | Volume 3 | Issue 5 | e2294